Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 4Observational 1Expanded_access 1

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Genitourinary 1

Conditions

Water Intoxication 1Osteosarcoma 1Hematologic Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Acute Kidney Injury 1

Interventions

Blood Specimen Collection 4Drug Therapy 3mifamurtide 2Surveys and Questionnaires 2Psychiatric Rehabilitation 2Patient Reported Outcome Measures 2Methotrexate 2glucarpidase 1X-Rays 1Weight-Bearing 1Tomography, X-Ray Computed 1Therapeutics 1Surgical Procedures, Operative 1Specimen Handling 1Reverse Transcriptase Polymerase Chain Reaction 1Range of Motion, Articular 1Radiotherapy 1Quality of Life 1Positron-Emission Tomography 1Polymerase Chain Reaction 1Molecular Diagnostic Techniques 1Microbiota 1Microarray Analysis 1Metabolome 1Medical Records 1Magnetic Resonance Imaging 1In Situ Hybridization, Fluorescence 1Immunotherapy 1HMPL-013 1Gene Rearrangement 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Osteosarcoma × glucarpidase × Clear all
NCT05899751 2024-05-10

Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate

BTG International Inc.

Unknown
1,000 enrolled
GenitourinaryOther hematologic neoplasmSarcoma

Osteosarcoma, Water Intoxication, Hematologic Neoplasms, Acute Kidney Injury, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡